Nucleo-cytoplasmic localization domains regulate krü ppel-like factor 6 (KLF6) protein stability and tumor suppressor function

PLoS ONE

Volumn 5, Issue 9, 2010, Pages 1-13

  Rodríguez, Estefanía ^a   Aburjania, Nana ^a   Priedigkeit, Nolan M ^a   Difeo, Analisa ^a   Martignetti, John A ^a  

^a MOUNT SINAI SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EXPORTIN 1; KRUPPEL LIKE FACTOR 6; PROTEIN P21; UVOMORULIN; KLF6 PROTEIN, HUMAN; KRUPPEL LIKE FACTOR; ONCOPROTEIN;

AMINO TERMINAL SEQUENCE; ARTICLE; CONTROLLED STUDY; NUCLEAR EXPORT SIGNAL; NUCLEAR LOCALIZATION SIGNAL; PROTEIN DOMAIN; PROTEIN FUNCTION; PROTEIN LOCALIZATION; PROTEIN METABOLISM; PROTEIN STABILITY; PROTEIN TRANSPORT; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SITE DIRECTED MUTAGENESIS; ZINC FINGER MOTIF; ACTIVE TRANSPORT; AMINO ACID SEQUENCE; CELL LINE; CELL NUCLEUS; CHEMISTRY; GENETICS; HALF LIFE TIME; HUMAN; METABOLISM; MOLECULAR GENETICS; PROTEIN TERTIARY STRUCTURE;

ACTIVE TRANSPORT, CELL NUCLEUS; AMINO ACID SEQUENCE; CELL LINE; CELL NUCLEUS; HALF-LIFE; HUMANS; KRUPPEL-LIKE TRANSCRIPTION FACTORS; MOLECULAR SEQUENCE DATA; NUCLEAR EXPORT SIGNALS; NUCLEAR LOCALIZATION SIGNALS; PROTEIN STABILITY; PROTEIN STRUCTURE, TERTIARY; PROTO-ONCOGENE PROTEINS;

EID: 77958610252     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0012639     Document Type: Article

References (55)

1. Narla G, Heath KE, Reeves HL, Li D, Giono LE, et al. (2001) KLF6, a candidate tumor suppressor gene mutated in prostate cancer. Science 294: 2563-2566.
2. Black AR, Black JD, Azizkhan-Clifford J (2001) Sp1 and krüppel-like factor family of transcription factors in cell growth regulation and cancer. J Cell Physiol 188: 143-160.
3. DiFeo A, Narla G, Hirshfeld J, Camacho-Vanegas O, Narla J, et al. (2006) Roles of KLF6 and KLF6-SV1 in ovarian cancer progression and intraperitoneal dissemination. Clin Cancer Res 12: 3730-3739.
4. Camacho-Vanegas O, Narla G, Teixeira MS, DiFeo A, Misra A, et al. (2007) Functional inactivation of the KLF6 tumor suppressor gene by loss of heterozygosity and increased alternative splicing in glioblastoma. Int J Cancer 121: 1390-1395.
5. Chen C, Hyytinen ER, Sun X, Helin HJ, Koivisto PA, et al. (2003) Deletion, mutation, and loss of expression of KLF6 in human prostate cancer. Am J Pathol 162: 1349-1354.
6. Reeves HL, Narla G, Ogunbiyi O, Haq AI, Katz A, et al. (2004) Kruppel-like factor 6 (KLF6) is a tumor-suppressor gene frequently inactivated in colorectal cancer. Gastroenterology 126: 1090-1103.
7. Kremer-Tal S, Reeves HL, Narla G, Thung SN, Schwartz M, et al. (2004) Frequent inactivation of the tumor suppressor Kruppel-like factor 6 (KLF6) in hepatocellular carcinoma. Hepatology 40: 1047-1052.
8. Kremer-Tal S, Narla G, Chen Y, Hod E, DiFeo A, et al. (2007) Downregulation of KLF6 is an early event in hepatocarcinogenesis, and stimulates proliferation while reducing differentiation. J Hepatol 46: 645-654.
9. Kettunen E, Anttila S, Seppänen JK, Karjalainen A, Edgren H, et al. (2004) Differentially expressed genes in nonsmall cell lung cancer: expression profiling of cancer-related genes in squamous cell lung cancer. Cancer Genet Cytogenet 149: 98-106.
10. Ito G, Uchiyama M, Kondo M, Mori S, Usami N, et al. (2004) Krü ppel-like factor 6 is frequently down-regulated and induces apoptosis in non-small cell lung cancer cells. Cancer Res 64: 3838-3843.
11. Cho YG, Kim CJ, Park CH, Yang YM, Kim SY, et al. (2005) Genetic alterations of the KLF6 gene in gastric cancer. Oncogene 24: 4588-4590.
12. Cho YG, Lee HS, Song JH, Kim CJ, Park YK, et al. (2008) KLF6 IVS1 -27G/A polymorphism with susceptibility to gastric cancers in Korean. Neoplasma 55: 47-50.
13. Teixeira MS, Camacho-Vanegas O, Fernandez Y, Narla G, DiFeo A, et al. (2007) KLF6 allelic loss is associated with tumor recurrence and markedly decreased survival in head and neck squamous cell carcinoma. Int J Cancer 121: 1976-1983.
14. Chen HK, Liu XQ, Lin J, Chen TY, Feng QS, et al. (2002) Mutation analysis of KLF6 gene in human nasopharyngeal carcinomas. Ai Zheng 21: 1047-1050.
15. Pearson R, Fleetwood J, Eaton S, Crossley M, Bao S (2008) Krü ppel-like transcription factors: a functional family. Int J Biochem Cell Biol 40: 1996-2001.
16. Narla G, Difeo A, Reeves HL, Schaid DJ, Hirshfeld J, et al. (2005) A germline DNA polymorphism enhances alternative splicing of the KLF6 tumor suppressor gene and is associated with increased prostate cancer risk. Cancer Res 65: 1213-1222.
17. Narla G, DiFeo A, Yao S, Banno A, Hod E, et al. (2005) Targeted inhibition of the KLF6 splice variant, KLF6 SV1, suppresses prostate cancer cell growth and spread. Cancer Res 65: 5761-5768.
18. Spinola M, Leoni VP, Galvan A, Korsching E, Conti B, et al. (2007) Genomewide single nucleotide polymorphism analysis of lung cancer risk detects the KLF6 gene. Cancer Lett 251: 311-316.
19. Hartel M, Narla G, Wente MN, Giese NA, Martignoni ME, et al. (2008) Increased alternative splicing of the KLF6 tumour suppressor gene correlates with prognosis and tumour grade in patients with pancreatic cancer. Eur J Cancer 44: 1895-1903.
20. Shields JM, Yang VW (1997) Two potent nuclear localization signals in the gutenriched Krü ppel-like factor define a subfamily of closely related Krüppel proteins. J Biol Chem 272: 18504-18507.
21. Pandya K, Townes TM (2002) Basic residues within the Kruppel zinc finger DNA binding domains are the critical nuclear localization determinants of EKLF/KLF-1. J Biol Chem: 277: 16304-16312.
22. Quadrini KJ, Bieker JJ (2002) Krü ppel-like zinc fingers bind to nuclear import proteins and are required for efficient nuclear localization of erythroid Krüppellike factor. J Biol Chem 277: 32243-32252.
23. Mehta TS, Lu H, Wang X, Urvalek AM, Nguyen KH, et al. (2009) A unique sequence in the N-terminal regulatory region controls the nucleus. Cell Res 19: 1098-109.
24. Du JX, Bialkowska AB, McConnell BB, Yang VW (2008) SUMOylation regulates nuclear localization of Krüppel-like factor 5. J Biol Chem 283: 31991-32002.
25. Kalderon D, Roberts BL, Richardson WD, Smith AE (1984) A short amino acid sequence able to specify nuclear location. Cell 39: 499-509.
26. Robbins J, Dilworth SM, Laskey RA, Dingwall C (1991) Two interdependent basic domains in nucleoplasmin nuclear targeting sequence: identification of a class of bipartite nuclear targeting sequence. Cell 64: 615-623.
27. Adam SA, Gerace L (1991) Cytosolic proteins that specifically bind nuclear location signals are receptors for nuclear import. Cell 66: 837-847.
28. O'Neill RE, Jaskunas R, Blobel G, Palese P, Moroianu J (1995) Nuclear import of influenza virus RNA can be mediated by viral nucleoprotein and transport factors required for protein import. J Biol Chem 270: 22701-22704.
29. Macara IG (2001) Transport into and out of the nucleus. Microbiol Mol Biol Rev 65: 570-594.
30. Boulikas T (1994) Putative nuclear localization signals (NLS) in protein transcription factors. J Cell Biochem 55: 32-58.
31. Fischer U, Huber J, Boelens WC, Mattaj IW, Lührmann R (1995) The HIV-1 Rev activation domain is a nuclear export signal that accesses an export pathway used by specific cellular RNAs. Cell 82: 475-483.
32. Wen W, Meinkoth JL, Tsien RY, Taylor SS (1995) Identification of a signal for rapid export of proteins from the nucleus. Cell 82: 463-473.
33. Fornerod M, van Deursen J, van Baal S, Reynolds A, Davis D, et al. (1997) The human homologue of yeast CRM1 is in a dynamic subcomplex with CAN/Nup214 and a novel nuclear pore component Nup88. EMBO J 16: 807-816.
34. Ossareh-Nazari B, Bachelerie F, Dargemont C (1997) Evidence for a role of CRM1 in signal-mediated nuclear protein export. Science 278: 141-144.
35. Adachi Y, Yanagida M (1989) Higher order chromosome structure is affected by cold-sensitive mutations in a Schizosaccharomyces pombe gene crm1+ which encodes a 115-kD protein preferentially localized in the nucleus and its periphery. J Cell Biol 108: 1195-1207.
36. Hutten S, Kehlenbach RH (2007) CRM1-mediated nuclear export: to the pore and beyond. Trends Cell Biol 17: 193-201.
37. Jiao W, Datta J, Lin HM, Dundr M, Rane SG (2006) Nucleocytoplasmic shuttling of the retinoblastoma tumor suppressor protein via Cdk phosphorylation-dependent nuclear export. J Biol Chem 281: 38098-38108.
38. Planchon SM, Waite KA, Eng C (2008) The nuclear affairs of PTEN. J Cell Sci 121: 249-253.
39. Fabbro M, Henderson BR (2003) Regulation of tumor suppressors by nuclearcytoplasmic shuttling. Exp Cell Res 282: 59-69.
40. Kau TR, Schroeder F, Ramaswamy S, Wojciechowski CL, Zhao JJ, et al. (2003) A chemical genetic screen identifies inhibitors of regulated nuclear export of a Forkhead transcription factor in PTEN-deficient tumor cells. Cancer Cell 4: 463-476.
41. Jiao W, Lin HM, Datta J, Braunschweig T, Chung JY, et al. (2008) Aberrant nucleocytoplasmic localization of the retinoblastoma tumor suppressor protein in human cancer correlates with moderate/poor tumor differentiation. Oncogene 27: 3156-3164.
42. Salmena L, Pandolfi PP (2007) Changing venues for tumour suppression: balancing destruction and localization by monoubiquitylation. Nat Rev Cancer 7: 409-413.
43. Kudo N, Wolff B, Sekimoto T, Schreiner EP, Yoneda Y, et al. (1998) Leptomycin B inhibition of signal-mediated nuclear export by direct binding to CRM1. Exp Cell Res 242: 540-547.
44. Kudo N, Matsumori N, Taoka H, Fujiwara D, Schreiner EP, et al. (1999) Leptomycin B inactivates CRM1/exportin 1 by covalent modification at a cysteine residue in the central conserved region. Proc Natl Acad Sci U S A 96: 9112-9117.
45. Henderson BR, Eleftheriou A (2000) A comparison of the activity, sequence specificity, and CRM1-dependence of different nuclear export signals. Exp Cell Res 256: 213-224.
46. Jeng YM, Hsu HC (2003) KLF6, a putative tumor suppressor gene, is mutated in astrocytic gliomas. Int J Cancer 105: 625-629.
47. Banck MS, Beaven SW, Narla G, Walsh MJ, Friedman SL, et al. (2006) KLF6 degradation after apoptotic DNA damage. FEBS Lett 580: 6981-6986.
48. DiFeo A, Narla G, Camacho-Vanegas O, Nishio H, Rose SL, et al. (2006) Ecadherin is a novel transcriptional target of the KLF6 tumor suppressor. Oncogene 25: 6026-6031.
49. Yamashita K, Upadhyay S, Osada M, Hoque MO, Xiao Y, et al. (2002) Pharmacologic unmasking of epigenetically silenced tumor suppressor genes in esophageal squamous cell carcinoma. Cancer Cell 2: 485-495.
50. Yin D, Komatsu N, Miller CW, Chumakov AM, Marschesky A, et al. (2007) KLF6: mutational analysis and effect on cancer cell proliferation. Int J Oncol 30: 65-72.
51. DiFeo A, Feld L, Rodriguez E, Wang C, Beer DG, et al. (2008) A functional role for KLF6-SV1 in lung adenocarcinoma prognosis and chemotherapy response. Cancer Res 68: 965-970.
52. Narla G, DiFeo A, Fernandez Y, Dhanasekaran S, Huang F, et al. (2008) KLF6-SV1 overexpression accelerates human and mouse prostate cancer progression and metastasis. J Clin Invest 118: 2711-2721.
53. Fabbro M, Rodriguez JA, Baer R, Henderson BR (2002) BARD1 induces BRCA1 intranuclear foci formation by increasing RING-dependent BRCA1 nuclear import and inhibiting BRCA1 nuclear export. J Biol Chem 277: 21315-21324.
54. Difeo A, Huang F, Sangodkar J, Terzo EA, Leake D, et al. (2009) KLF6-SV1 is a novel antiapoptotic protein that targets the BH3-only protein NOXA for degradation and whose inhibition extends survival in an ovarian cancer model. Cancer Res 69: 4733-4741.
55. Nagai R, Friedman SL, Kasuga M, eds (2009) The biology of Krü ppel-like Factors. Springer. pp 226-229.